Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/1999
08/24/1999US5942251 Pharmaceutical compositions for intranasal administration of dihydroergotamine
08/24/1999US5942241 A sustained release drug containing a substrate comprising a local anesthetic and a biocompatible, biodegradable, controlled release polymer selected from polyanhydrides, lactic acid and glycolic acid homo-or/and copolymers
08/24/1999CA2248972A1 Novel compounds
08/24/1999CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/20/1999CA2249653A1 Novel compounds
08/19/1999WO1999041396A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999WO1999041267A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999WO1999041251A1 Antagonists of gonadotropin releasing hormone
08/19/1999WO1999041247A1 TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND Th2-ENHANCING CYTOKINES
08/19/1999WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
08/19/1999WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999WO1999041220A1 Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease
08/19/1999WO1999040946A2 Methods and compositions for modulating leptin activity
08/19/1999WO1999040931A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
08/19/1999WO1999040918A1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations
08/19/1999WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999WO1999040910A1 Anti-inflammatory agents
08/19/1999WO1999040909A1 Method for modulating macrophage activation
08/19/1999WO1999040905A2 Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases
08/19/1999WO1999040867A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor
08/19/1999WO1999030741A3 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
08/19/1999WO1999030694A3 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
08/19/1999WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
08/19/1999WO1999025354A3 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
08/19/1999WO1999024451A3 Adenosine a1 receptor agonists
08/19/1999WO1999024450A3 Adensine a1 receptor agonists
08/19/1999WO1999024449A3 Adenosine a1 receptor agonists
08/19/1999WO1999024394A3 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/19/1999WO1999024076A3 Salicylate derivatized therapeutic and diagnostic agents
08/19/1999WO1999024074A3 Novel conjugates of opioids and endogenous carriers
08/19/1999WO1999024058A3 Neuronal uses of bmp-11
08/19/1999WO1999023996A3 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor
08/19/1999WO1998008966A8 Loxoprofen-containing preparation for external use
08/19/1999DE19859526A1 Pharmaceutical composition, especially for gene transfer and therapy
08/19/1999DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments
08/19/1999CA2632106A1 Method for modulating macrophage activation
08/19/1999CA2321220A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999CA2320934A1 Treatment of brain edema using carbonic anhydrase inhibitor
08/19/1999CA2320378A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
08/19/1999CA2320285A1 Anti-inflammatory agents
08/19/1999CA2320226A1 Methods and compositions for modulating leptin activity
08/19/1999CA2320154A1 Use of hyperforin and hyperforin-containing extracts for the treatment and prophylaxis of dementia diseases
08/19/1999CA2320091A1 Stable hyperforin salts, methods of manufacturing them, and their use for the treatment of alzheimer's disease
08/19/1999CA2320044A1 Treatment of multiple sclerosis using cop-1 and th2-enhancing cytokines
08/19/1999CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999CA2319009A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999CA2317451A1 Antagonists of gonadotropin releasing hormone
08/18/1999EP0935657A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
08/18/1999EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use
08/18/1999EP0935653A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
08/18/1999EP0935601A2 Arylamino fused pyridines and pyrimidines
08/18/1999EP0935599A1 2-methoxyphenylpiperazine derivatives
08/18/1999EP0935598A1 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
08/18/1999EP0935465A1 Novel substituted imidazole compounds
08/18/1999EP0935464A1 Inhibitors of farnesyl-protein transferase
08/18/1999EP0935463A2 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
08/18/1999EP0935461A1 Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals
08/18/1999EP0792292B1 Orphan receptor
08/18/1999EP0759026B1 Amide derivatives and their therapeutic use
08/18/1999EP0697869B1 Transdermal therapeutic systems for the administration of serotonin agonists
08/18/1999EP0620817B1 Piperazine derivatives as 5-ht receptors antagonists
08/18/1999CN1226234A New derivatives of 10,11-dihydro-10-oxo-5H-dibenz/b,f/azepine-5-carboxamide
08/18/1999CN1226165A Method for treating bipolar disorder
08/18/1999CN1226163A Formulation for treatment and/or prevention of dementia
08/18/1999CN1226152A Transdermal propentofylline compositions for treatment of alzheimer's disease
08/18/1999CN1044705C (1-phenyl-1-heterocyclyl) alkane derivatives and their preparation method and use
08/17/1999US5939462 NPY5 receptor antagonists and methods for using same
08/17/1999US5939451 Use of sulfonamides
08/17/1999US5939449 Novel compounds having high affinity for the neurotensin receptors
08/17/1999US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists
08/17/1999US5939433 Quinuclidine derivatives
08/17/1999US5939432 Thiophenes useful for modulating the adenosine receptor
08/17/1999US5939425 Method for treating a migraine
08/17/1999US5939422 An enzyme inhibitor as bronchodilator, relaxants, antiinflammatory agent for treating asthma, allergies, inflammation, depression, dementia, diseases associated with abnormal high level of cytokine
08/17/1999US5939415 A!-annellated pyrrole derivatives and their use in pharmacology
08/17/1999US5939413 Tachykinin mediated diseases in humans for respiratory system disorders like asthma, bronchitis, rhinitis or eye diseases or skin disorders
08/17/1999US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies
08/17/1999US5939407 Vitamin d receptors for nervous system disorders
08/17/1999US5939405 Potassium channel modulators
08/17/1999US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents
08/17/1999US5939271 Recombinant nucleic acid molecule coding for polypeptide which has cell and neuron chemotactic functions; diagnosis, gene therapy, immunogens
08/17/1999US5939095 At least one parasympathomimetically active substance and at least one parasympatholytically active substance
08/17/1999US5939076 Composition and method for treating or alleviating migraine headaches
08/17/1999CA2195622C Process for preparing trans-piperidine-2,5-dicarboxylates
08/17/1999CA2105180C Compositions containing sumatriptan
08/17/1999CA2098738C Controlled release oxycodone compositions
08/17/1999CA2002483C Fluoxetine analog
08/12/1999WO1999040225A1 Immediate early genes and methods of use therefor
08/12/1999WO1999040220A2 Method of screening therapeutic agents
08/12/1999WO1999040207A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
08/12/1999WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999WO1999040112A1 Neuroprotective peptides and uses thereof
08/12/1999WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
1 ... 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 ... 1833